AKT1 and cancer: Through S1P/S1PR1 signaling, ApoM activates the downstream signaling pathways including ERK1/2 and PI3K/AKT pathways, which promote cancer cell proliferation and invasion in vitro and tumor growth in vivo (Zhu et al., 2018).